NZ241757A - Treating cellulite with a retinoid - Google Patents

Treating cellulite with a retinoid

Info

Publication number
NZ241757A
NZ241757A NZ241757A NZ24175792A NZ241757A NZ 241757 A NZ241757 A NZ 241757A NZ 241757 A NZ241757 A NZ 241757A NZ 24175792 A NZ24175792 A NZ 24175792A NZ 241757 A NZ241757 A NZ 241757A
Authority
NZ
New Zealand
Prior art keywords
retinoid
cellulite
retinoic acid
amount
acid
Prior art date
Application number
NZ241757A
Other languages
English (en)
Inventor
Albert Montgomery Kligman
Original Assignee
Kligman Albert M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kligman Albert M filed Critical Kligman Albert M
Publication of NZ241757A publication Critical patent/NZ241757A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Physical Vapour Deposition (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ241757A 1991-02-27 1992-02-27 Treating cellulite with a retinoid NZ241757A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/661,753 US5051449A (en) 1991-02-27 1991-02-27 Treatment of cellulite with retinoids

Publications (1)

Publication Number Publication Date
NZ241757A true NZ241757A (en) 1994-04-27

Family

ID=24654977

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ241757A NZ241757A (en) 1991-02-27 1992-02-27 Treating cellulite with a retinoid

Country Status (17)

Country Link
US (1) US5051449A (OSRAM)
EP (1) EP0573601B1 (OSRAM)
JP (1) JP2893483B2 (OSRAM)
KR (1) KR100224284B1 (OSRAM)
AT (1) ATE172113T1 (OSRAM)
AU (1) AU666303B2 (OSRAM)
CA (1) CA2104452C (OSRAM)
DE (1) DE69227306T2 (OSRAM)
DK (1) DK0573601T3 (OSRAM)
ES (1) ES2124725T3 (OSRAM)
FI (1) FI103950B1 (OSRAM)
HU (1) HU218914B (OSRAM)
IE (1) IE920624A1 (OSRAM)
NO (1) NO304727B1 (OSRAM)
NZ (1) NZ241757A (OSRAM)
SG (1) SG69981A1 (OSRAM)
WO (1) WO1992015293A1 (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134163A (en) * 1989-09-01 1992-07-28 Kligman Albert M Methods of preventing and reducing the size of striae distensae lesions
US5521221A (en) * 1991-04-09 1996-05-28 Sloan-Kettering Institute For Cancer Research Retro-α-retinol (4,14-retro-retinol) derivatives and uses of retro-α-retinol
JP2765354B2 (ja) * 1992-03-09 1998-06-11 住友電装株式会社 接続具における電線の敷線方法
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US5587396A (en) * 1994-08-26 1996-12-24 Mary Kay Inc. Method of ameliorating cellulite by disrupting the barrier function of the stratum corneum
US5529769A (en) 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
DE69531559D1 (de) * 1995-10-18 2003-09-25 Mary Kay Inc Topisch angewandte strukturelle behandlungen der zellulitis
EP0866693B1 (en) * 1995-10-18 2003-08-20 Mary Kay Inc. Topically applied, structural cellulite treatments
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6982284B1 (en) 1999-09-10 2006-01-03 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
EP1720605A4 (en) * 2003-06-23 2007-10-24 Transpharma Medical Ltd TRANSDERMAL DELIVERY SYSTEM FOR COSMETIC AGENTS
FR2863492B1 (fr) * 2003-12-10 2007-08-24 Oreal Utilisation des modulateurs d'aquaglyceroporines comme amincissant
DE102004002606A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut
US20070025950A1 (en) * 2005-07-28 2007-02-01 Elson Melvin L Composition and method for treating cellulite
WO2008025368A1 (en) * 2006-08-30 2008-03-06 Merck Patent Gmbh Use of chromen-4-one derivatives
DE602007002276D1 (de) 2007-03-20 2009-10-15 Zusammensetzung enthältend Retinoid und Beta-aminoisobuttersäurederivate
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
DE102010054149A1 (de) 2010-12-10 2012-06-14 Merck Patent Gmbh 2-Pyrone
BR112018008556A2 (pt) 2015-10-30 2018-10-23 Patagonia Pharmaceuticals Llc ?composições farmacêuticas e métodos para tratar ictiose congênita?

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4288633A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11-deoxy-16-hydroxy-prosten-1-ol-derivatives
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
MY106263A (en) * 1989-01-19 1995-04-29 Ortho Pharma Corp Method for the treatment or prevention of intrinsically aged skin with retinoids
US5070108A (en) * 1990-10-12 1991-12-03 Trustees Of The University Of Pennsylvania Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal
MX9201084A (es) * 1991-04-15 1992-12-21 Bristol Myers Squibb Co Hiper pigmentacion de la piel

Also Published As

Publication number Publication date
JPH06507395A (ja) 1994-08-25
KR930702992A (ko) 1993-11-29
NO304727B1 (no) 1999-02-08
CA2104452C (en) 2002-07-16
HU218914B (hu) 2000-12-28
FI933736L (fi) 1993-08-25
CA2104452A1 (en) 1992-08-28
DE69227306D1 (de) 1998-11-19
EP0573601A4 (OSRAM) 1994-01-12
FI103950B (fi) 1999-10-29
DK0573601T3 (da) 1999-06-23
IE920624A1 (en) 1992-09-09
KR100224284B1 (ko) 1999-10-15
JP2893483B2 (ja) 1999-05-24
WO1992015293A1 (en) 1992-09-17
ES2124725T3 (es) 1999-02-16
SG69981A1 (en) 2000-01-25
AU666303B2 (en) 1996-02-08
FI933736A0 (fi) 1993-08-25
HUT65651A (en) 1994-07-28
DE69227306T2 (de) 1999-06-02
EP0573601B1 (en) 1998-10-14
ATE172113T1 (de) 1998-10-15
AU1644892A (en) 1992-10-06
NO932949L (no) 1993-08-19
EP0573601A1 (en) 1993-12-15
HU9302437D0 (en) 1993-11-29
NO932949D0 (no) 1993-08-19
US5051449A (en) 1991-09-24
FI103950B1 (fi) 1999-10-29

Similar Documents

Publication Publication Date Title
US5051449A (en) Treatment of cellulite with retinoids
US4888342A (en) Methods for treatment of sundamaged human skin with retinoids
US4877805A (en) Methods for treatment of sundamaged human skin with retinoids
AU599135B2 (en) Methods for treatment of sundamaged human skin with retinoids
US6008254A (en) Method of treating skin disorders with high-strength tretinoin
USRE36068E (en) Methods for treatment of sundamaged human skin with retinoids
US5468495A (en) Methods of preventing and reducing the size of Striae distensae lesions
CA1326633C (en) Treatment of aged skin with oral 13-cis-retinoic acid
WO1992015290A1 (en) Methods for treatment of scarring fibrotic alopecia
Harris Treatment of the aging skin with glycolic acid

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)